These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10505224)

  • 1. Graves' disease presenting with cholestatic jaundice.
    Barnes SC; Wicking JM; Johnston JD
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():677-9. PubMed ID: 10505224
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of severe cholestatic jaundice associated with Graves' disease.
    Soysal D; Tatar E; Solmaz S; Kabayeğit O; Tunakan M; Unsal B; Cevik C
    Turk J Gastroenterol; 2008 Mar; 19(1):77-9. PubMed ID: 18386249
    [No Abstract]   [Full Text] [Related]  

  • 3. Graves' disease presenting with severe cholestasis.
    Regelmann MO; Miloh T; Arnon R; Morotti R; Kerkar N; Rapaport R
    Thyroid; 2012 Apr; 22(4):437-9. PubMed ID: 22458973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinico-investigative profile in Graves' ophthalmopathy.
    Khurana AK; Sunder S; Ahluwalia BK; Malhotra KC; Gupta S
    Indian J Ophthalmol; 1992; 40(2):56-8. PubMed ID: 1452284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal hypothyroxinemia with normal thyrotropin. Clue to maternal Graves' disease.
    Slyper AH; Shaker JL
    Clin Pediatr (Phila); 1993 Feb; 32(2):121-3. PubMed ID: 8094332
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice. Graves' disease.
    Brent GA
    N Engl J Med; 2008 Jun; 358(24):2594-605. PubMed ID: 18550875
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
    Hyman BN; Johnson PC
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic granulomatosis in a patient with Graves' disease.
    Cathébras PJ; Mosnier JF; Gouilloud S; Bouchou K; Rousset H
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):905-8. PubMed ID: 8574726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of newborns of mothers with Graves' disease.
    Levy-Shraga Y; Tamir-Hostovsky L; Boyko V; Lerner-Geva L; Pinhas-Hamiel O
    Thyroid; 2014 Jun; 24(6):1032-9. PubMed ID: 24472020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anicteric cholestasis: a rare hepatic dysfunction caused by hyperthyroidism].
    Khelifi D; Nacef IB; Rojbi I; Mchirgui N; Khiari K
    Pan Afr Med J; 2019; 34():215. PubMed ID: 32180887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss and severe jaundice in a patient with hyperthyroidism.
    Breidert M; Offensperger S; Blum HE; Fischer R
    Z Gastroenterol; 2011 Sep; 49(9):1267-9. PubMed ID: 21887664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of thyrotropin receptor antibody (TRAb) levels in Graves' disease.
    Wilson R; McKillop JH; Thomson JA
    Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():601-2. PubMed ID: 1981965
    [No Abstract]   [Full Text] [Related]  

  • 14. Uveitis in patients with Graves' disease.
    Mizoguchi T; Amemiya T
    Metab Pediatr Syst Ophthalmol (1985); 1991; 14(2):42-3. PubMed ID: 1369643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graves' disease after 131I therapy for toxic nodule.
    Soule J; Mayfield R
    Thyroid; 2001 Jan; 11(1):91-2. PubMed ID: 11272103
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in thyroid functions in patients with euthyroid Graves' disease.
    Tamai H; Nakagawa T; Ohsako N; Fukino O; Takahashi H; Matsuzuka F; Kuma K; Nagataki S
    J Clin Endocrinol Metab; 1980 Jan; 50(1):108-12. PubMed ID: 6765952
    [No Abstract]   [Full Text] [Related]  

  • 17. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
    Clifton-Bligh P; Silverstein GE; Burke G
    J Clin Endocrinol Metab; 1974 Apr; 38(4):531-8. PubMed ID: 4206830
    [No Abstract]   [Full Text] [Related]  

  • 18. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
    Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
    Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.